# Host–Candida auris interactions in the skin

**Authors:** Shankar Thangamani, Abishek Balakumar, Abhishek Datta, Garrett Bryak, Michail S. Lionakis

PMC · DOI: 10.1371/journal.ppat.1014075 · PLOS Pathogens · 2026-03-27

## TL;DR

This paper reviews how Candida auris interacts with the skin, focusing on factors that allow it to colonize and cause infections.

## Contribution

The paper provides a comprehensive overview of host and fungal factors involved in C. auris skin colonization and infection.

## Key findings

- C. auris has a unique mannan outer layer and adhesins that aid in skin colonization.
- Host immune responses, including IL-17 and IFN-γ, influence the outcome of C. auris infection.
- Excessive IFN-γ responses contribute to epithelial pathology and fungal persistence.

## Abstract

Candida auris is an emerging, multidrug-resistant fungal pathogen that causes healthcare-associated outbreaks and life-threatening systemic infections. Unlike other Candida species, C. auris exhibits a distinct capacity for persistent skin colonization. In this review, we summarize our current understanding of clinical risk factors and host-microbe interactions that underlie C. auris skin colonization and infection. We discuss fungal determinants, including the unique mannan outer layer, fungal adhesins, the protein kinase Hog1, and other pathways in C. auris that govern adaptation in the skin. Furthermore, we highlight host immune mechanisms, including cytokine mediators (IL-1Ra, IL-17) and innate immune cells (neutrophils, macrophages, innate lymphocytes), that shape the outcome of C. auris skin colonization and infection. We also discuss how excessive IFN-γ responses drive epithelial pathology at the cutaneous barrier and enhance fungal persistence. Finally, we outline emerging research directions to understand host and microbe factors governing long-term colonization, with implications for developing novel therapeutic and vaccine strategies against this skin-tropic, multidrug-resistant fungal pathogen.

## Linked entities

- **Proteins:** hog-1 (HintN domain-containing protein)

## Full-text entities

- **Diseases:** IL-17 deficiency (OMIM:615607), invasive candidiasis (MESH:D058365), inflammation (MESH:D007249), chronic kidney disease (MESH:D051436), colonization (MESH:D003108), Malassezia infection (MESH:D014010), C. auris colonization (MESH:C000656864), Metabolic disorders (MESH:D008659), malignancy (MESH:D009369), atopic dermatitis (MESH:D003876), mucocutaneous candidiasis (MESH:D002177), neutropenia (MESH:D009503), diabetes (MESH:D003920), infected (MESH:D007239), systemic infections (MESH:D012141), fungemia (MESH:D016469), C. orthopsilosis (OMIM:211750), metabolic dysregulation (MESH:D021081), abscess (MESH:D000038), obesity (MESH:D009765), type 2 diabetes (MESH:D003924), autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) syndrome (MESH:D016884), Fungal (MESH:D009181)
- **Chemicals:** tetracycline (MESH:D013752), mannan (MESH:D008351), Cyclophosphamide (MESH:D003520), clodronate (MESH:D004002), fluconazole (MESH:D015725), glucose (MESH:D005947), TMP/SMX (MESH:D015662), AMPs (MESH:D000089882), free fatty acids (MESH:D005230), beta-glucan (MESH:D047071), reactive oxygen species (MESH:D017382), doxycycline (MESH:D004318), metronidazole (MESH:D008795), glyoxylate (MESH:C031150), amino acids (MESH:D000596), vancomycin (MESH:D014640), echinocandin (MESH:D054714), neomycin (MESH:D009355), ampicillin (MESH:D000667), iron (MESH:D007501), carbapenems (MESH:D015780), lipid (MESH:D008055), amphotericin B (MESH:D000666), azoles (MESH:D001393), AMNV (-), streptozotocin (MESH:D013311), carbon (MESH:D002244), fatty acid (MESH:D005227), chitin (MESH:D002686)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Klebsiella pneumoniae (species) [taxon 573], Providencia stuartii (species) [taxon 588], Malassezia furfur (Pityriasis (Tinea) versicolor infection agent, species) [taxon 55194], Acinetobacter baumannii (species) [taxon 470], Roseomonas mucosa (species) [taxon 207340], Canis lupus familiaris (dog, subspecies) [taxon 9615], Pseudomonas aeruginosa (species) [taxon 287], Proteus mirabilis (species) [taxon 584], Candidozyma auris (species) [taxon 498019], Candida [taxon 1535326], Staphylococcus capitis (species) [taxon 29388], Staphylococcus saprophyticus (species) [taxon 29385], Morganella morganii (species) [taxon 582], Anaerococcus nagyae (species) [taxon 1755241], Malassezia globosa (species) [taxon 76773], Lodderomyces parapsilosis (species) [taxon 5480], Staphylococcus epidermidis (species) [taxon 1282], Malassezia arunalokei (species) [taxon 1514897], Malassezia restricta (species) [taxon 76775], Homo sapiens (human, species) [taxon 9606], Nakaseomyces glabratus (species) [taxon 5478], Corynebacterium tuberculostearicum (species) [taxon 38304], Anaerococcus octavius (species) [taxon 54007], Mammaliicoccus lentus (species) [taxon 42858], Candida albicans (species) [taxon 5476], Staphylococcus aureus (species) [taxon 1280], Mus musculus (house mouse, species) [taxon 10090], Staphylococcus caprae (species) [taxon 29380], Peptoniphilus tyrrelliae (species) [taxon 755171], Staphylococcus hominis (species) [taxon 1290], Lodderomyces metapsilosis (species) [taxon 273372], Danio rerio (leopard danio, species) [taxon 7955]
- **Cell lines:** AR0387 — Homo sapiens (Human), Transformed cell line (CVCL_8Z65), AR0382 — Homo sapiens (Human), Transformed cell line (CVCL_8Z60)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028408/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028408/full.md

## References

126 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028408/full.md

---
Source: https://tomesphere.com/paper/PMC13028408